1
|
Manoj KM. Murburn posttranslational modifications of proteins: Cellular redox processes and murzyme-mediated metabolo-proteomics. J Cell Physiol 2024; 239:e30954. [PMID: 36716112 DOI: 10.1002/jcp.30954] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2022] [Revised: 01/04/2023] [Accepted: 01/11/2023] [Indexed: 01/31/2023]
Abstract
Murburn concept constitutes the thesis that diffusible reactive species or DRS are obligatorily involved in routine metabolic and physiological activities. Murzymes are defined as biomolecules/proteins that generate/modulate/sustain/utilize DRS. Murburn posttranslational modifications (PTMs) result because murburn/murzyme functionalism is integral to cellular existence. Cells must incorporate the inherently stochastic nature of operations mediated by DRS. Due to the earlier/inertial stigmatic perception that DRS are mere agents of chaos, several such outcomes were either understood as deterministic modulations sponsored by house-keeping enzymes or deemed as unregulated nonenzymatic events resulting out of "oxidative stress". In the current review, I dispel the myths around DRS-functions, and undertake systematic parsing and analyses of murburn modifications of proteins. Although it is impossible to demarcate all PTMs into the classical or murburn modalities, telltale signs of the latter are evident from the relative inaccessibility of the locus, non-specificities and mechanistic details. It is pointed out that while many murburn PTMs may be harmless, some others could have deleterious or beneficial physiological implications. Some details of reversible/irreversible modifications of amino acid residues and cofactors that may be subjected to phosphorylation, halogenation, glycosylation, alkylation/acetylation, hydroxylation/oxidation, etc. are listed, along with citations of select proteins where such modifications have been reported. The contexts of these modifications and their significance in (patho)physiology/aging and therapy are also presented. With more balanced explorations and statistically verified data, a definitive understanding of normal versus pathological contexts of murburn modifications would be obtainable in the future.
Collapse
|
2
|
Ulrich K. Redox-regulated chaperones in cell stress responses. Biochem Soc Trans 2023:233014. [PMID: 37140269 DOI: 10.1042/bst20221304] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2023] [Revised: 04/12/2023] [Accepted: 04/18/2023] [Indexed: 05/05/2023]
Abstract
Proteostasis and redox homeostasis are tightly interconnected and most protein quality control pathways are under direct redox regulation which allow cells to immediately respond to oxidative stress conditions. The activation of ATP-independent chaperones serves as a first line of defense to counteract oxidative unfolding and aggregation of proteins. Conserved cysteine residues evolved as redox-sensitive switches which upon reversible oxidation induce substantial conformational rearrangements and the formation of chaperone-active complexes. In addition to harnessing unfolding proteins, these chaperone holdases interact with ATP-dependent chaperone systems to facilitate client refolding and restoring proteostasis during stress recovery. This minireview gives an insight into highly orchestrated mechanisms regulating the stress-specific activation and inactivation of redox-regulated chaperones and their role in cell stress responses.
Collapse
Affiliation(s)
- Kathrin Ulrich
- Institute of Biochemistry, Cellular Biochemistry, University of Cologne, Zuelpicher Str. 47a, 50674 Cologne, Germany
| |
Collapse
|
3
|
Jurva U, Weidolf L, Sandinge AS, Leandersson C, Ekdahl A, Li XQ, Antonsson T, Sundell J, Westerlund K, Amilon C, Inghardt T, Gopaul VS. Biotransformation of the Novel Myeloperoxidase Inhibitor AZD4831 in Preclinical Species and Humans. Drug Metab Dispos 2023; 51:464-479. [PMID: 36653117 PMCID: PMC11022936 DOI: 10.1124/dmd.122.001099] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2022] [Revised: 11/17/2022] [Accepted: 12/15/2022] [Indexed: 01/19/2023] Open
Abstract
We report herein an in-depth analysis of the metabolism of the novel myeloperoxidase inhibitor AZD4831 ((R)-1-(2-(1-aminoethyl)-4-chlorobenzyl)-2-thioxo-2,3-dihydro-1H-pyrrolo[3,2-d]pyrimidin-4(5H)-one) in animals and human. Quantitative and qualitative metabolite profiling were performed on samples collected from mass balance studies in rats and humans. Exposure of circulating human metabolites with comparable levels in animal species used in safety assessment were also included. Structural characterization of 20 metabolites was performed by liquid chromatography high-resolution mass spectrometry, and quantification was performed by either 14C analysis using solid phase scintillation counting or accelerator mass spectrometry and, where available, authentication with synthesized metabolite standards. A complete mass balance study in rats is presented, while data from dogs and human are limited to metabolite profiling and characterization. The metabolism of AZD4831 is mainly comprised of reactions at the primary amine nitrogen and the thiourea sulfur, resulting in several conjugated metabolites with or without desulfurization. A carbamoyl glucuronide metabolite of AZD4831 (M7) was the most abundant plasma metabolite in both human healthy volunteers and heart failure patients after single and repeated dose administration of AZD4831, accounting for 75%-80% of the total drug-related exposure. Exposures to M7 and other human circulating metabolites were covered in rats and/or dogs, the two models most frequently used in the toxicology studies, and were also highly abundant in the mouse, the second model other than rat used in carcinogenicity studies. The carbamoyl glucuronide M7 was the main metabolite in rat bile, while a desulfurized and cyclized metabolite (M5) was abundant in rat plasma and excreta. SIGNIFICANCE STATEMENT: The biotransformation of AZD4831, a novel myeloperoxidase inhibitor inhibiting xanthine derivative bearing thiourea and primary aliphatic amine functions, is described. Twenty characterized metabolites demonstrate the involvement of carbamoylation with glucuronidation, desulfurization, and cyclization as main biotransformation reactions. The carbamoyl glucuronide was the main metabolite in human plasma, likely governed by a significant species difference in plasma protein binding for this metabolite, but this and other human plasma metabolites were covered in animals used in the toxicity studies.
Collapse
Affiliation(s)
- Ulrik Jurva
- Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (U.J., L.W., A-S.S., A.E., X.L., V.S.G.); Drug Metabolism and Pharmacokinetics, Research and Early Development, Respiratory and Immunology (C.L.), Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism (T.A., J.S., K.W., T.I.), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; and Formerly of AstraZeneca (L.W., C.A.)
| | - Lars Weidolf
- Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (U.J., L.W., A-S.S., A.E., X.L., V.S.G.); Drug Metabolism and Pharmacokinetics, Research and Early Development, Respiratory and Immunology (C.L.), Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism (T.A., J.S., K.W., T.I.), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; and Formerly of AstraZeneca (L.W., C.A.)
| | - Ann-Sofie Sandinge
- Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (U.J., L.W., A-S.S., A.E., X.L., V.S.G.); Drug Metabolism and Pharmacokinetics, Research and Early Development, Respiratory and Immunology (C.L.), Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism (T.A., J.S., K.W., T.I.), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; and Formerly of AstraZeneca (L.W., C.A.)
| | - Carina Leandersson
- Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (U.J., L.W., A-S.S., A.E., X.L., V.S.G.); Drug Metabolism and Pharmacokinetics, Research and Early Development, Respiratory and Immunology (C.L.), Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism (T.A., J.S., K.W., T.I.), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; and Formerly of AstraZeneca (L.W., C.A.)
| | - Anja Ekdahl
- Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (U.J., L.W., A-S.S., A.E., X.L., V.S.G.); Drug Metabolism and Pharmacokinetics, Research and Early Development, Respiratory and Immunology (C.L.), Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism (T.A., J.S., K.W., T.I.), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; and Formerly of AstraZeneca (L.W., C.A.)
| | - Xue-Qing Li
- Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (U.J., L.W., A-S.S., A.E., X.L., V.S.G.); Drug Metabolism and Pharmacokinetics, Research and Early Development, Respiratory and Immunology (C.L.), Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism (T.A., J.S., K.W., T.I.), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; and Formerly of AstraZeneca (L.W., C.A.)
| | - Thomas Antonsson
- Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (U.J., L.W., A-S.S., A.E., X.L., V.S.G.); Drug Metabolism and Pharmacokinetics, Research and Early Development, Respiratory and Immunology (C.L.), Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism (T.A., J.S., K.W., T.I.), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; and Formerly of AstraZeneca (L.W., C.A.)
| | - Johan Sundell
- Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (U.J., L.W., A-S.S., A.E., X.L., V.S.G.); Drug Metabolism and Pharmacokinetics, Research and Early Development, Respiratory and Immunology (C.L.), Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism (T.A., J.S., K.W., T.I.), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; and Formerly of AstraZeneca (L.W., C.A.)
| | - Kristina Westerlund
- Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (U.J., L.W., A-S.S., A.E., X.L., V.S.G.); Drug Metabolism and Pharmacokinetics, Research and Early Development, Respiratory and Immunology (C.L.), Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism (T.A., J.S., K.W., T.I.), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; and Formerly of AstraZeneca (L.W., C.A.)
| | - Carl Amilon
- Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (U.J., L.W., A-S.S., A.E., X.L., V.S.G.); Drug Metabolism and Pharmacokinetics, Research and Early Development, Respiratory and Immunology (C.L.), Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism (T.A., J.S., K.W., T.I.), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; and Formerly of AstraZeneca (L.W., C.A.)
| | - Tord Inghardt
- Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (U.J., L.W., A-S.S., A.E., X.L., V.S.G.); Drug Metabolism and Pharmacokinetics, Research and Early Development, Respiratory and Immunology (C.L.), Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism (T.A., J.S., K.W., T.I.), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; and Formerly of AstraZeneca (L.W., C.A.)
| | - V Sashi Gopaul
- Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (U.J., L.W., A-S.S., A.E., X.L., V.S.G.); Drug Metabolism and Pharmacokinetics, Research and Early Development, Respiratory and Immunology (C.L.), Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism (T.A., J.S., K.W., T.I.), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; and Formerly of AstraZeneca (L.W., C.A.)
| |
Collapse
|
4
|
Redox-Mediated Inactivation of the Transcriptional Repressor RcrR is Responsible for Uropathogenic Escherichia coli's Increased Resistance to Reactive Chlorine Species. mBio 2022; 13:e0192622. [PMID: 36073817 PMCID: PMC9600549 DOI: 10.1128/mbio.01926-22] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Abstract
The ability to overcome stressful environments is critical for pathogen survival in the host. One challenge for bacteria is the exposure to reactive chlorine species (RCS), which are generated by innate immune cells as a critical part of the oxidative burst. Hypochlorous acid (HOCl) is the most potent antimicrobial RCS and is associated with extensive macromolecular damage in the phagocytized pathogen. However, bacteria have evolved defense strategies to alleviate the effects of HOCl-mediated damage. Among these are RCS-sensing transcriptional regulators that control the expression of HOCl-protective genes under non-stress and HOCl stress. Uropathogenic Escherichia coli (UPEC), the major causative agent of urinary tract infections (UTIs), is particularly exposed to infiltrating neutrophils during pathogenesis; however, their responses to and defenses from HOCl are still completely unexplored. Here, we present evidence that UPEC strains tolerate higher levels of HOCl and are better protected from neutrophil-mediated killing compared with other E. coli. Transcriptomic analysis of HOCl-stressed UPEC revealed the upregulation of an operon consisting of three genes, one of which encodes the transcriptional regulator RcrR. We identified RcrR as a HOCl-responsive transcriptional repressor, which, under non-stress conditions, is bound to the operator and represses the expression of its target genes. During HOCl exposure, however, the repressor forms reversible intermolecular disulfide bonds and dissociates from the DNA resulting in the derepression of the operon. Deletion of one of the target genes renders UPEC significantly more susceptible to HOCl and phagocytosis indicating that the HOCl-mediated induction of the regulon plays a major role for UPEC’s HOCl resistance.
Collapse
|
5
|
Gorudko IV, Grigorieva DV, Shamova EV, Gorbunov NP, Kokhan AU, Kostevich VA, Vasilyev VB, Panasenko OM, Khinevich NV, Bandarenka HV, Burko AA, Sokolov AV. Structure-biological activity relationships of myeloperoxidase to effect on platelet activation. Arch Biochem Biophys 2022; 728:109353. [PMID: 35853481 DOI: 10.1016/j.abb.2022.109353] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2022] [Revised: 06/28/2022] [Accepted: 07/11/2022] [Indexed: 11/26/2022]
Abstract
Myeloperoxidase (MPO), an oxidant-producing enzyme of neutrophils, has been shown to prime platelet activity promoting immunothrombosis. Native MPO is a homodimer, consisting of two identical protomers (monomer) connected by a single disulfide bond. But in inflammatory foci, MPO can be found both in the form of a monomer and in the form of a dimer. Beside MPO can also be in complexes with other molecules and be modified by oxidants, which ultimately affect its physicochemical properties and functions. Here we compared the effects of various forms of MPO as well as MPO in complex with ceruloplasmin (CP), a physiological inhibitor of MPO, on the platelet activity. Monomeric MPO (hemi-MPO) was obtained by treating the dimeric MPO by reductive alkylation. MPO was modified with HOCl in a molar ratio of 1:100 (MPO-HOCl). Using surface-enhanced Raman scattering (SERS) spectroscopy we showed that peaks at about 510 and 526 cm-1 corresponded to disulfide bond was recognizable in the SERS-spectra of dimeric MPO, absent in the spectrum of hemi-MPO and less intense in the spectra of MPO-HOCl, which indicates the partial decomposition of dimeric MPO with a disulfide bond cleavage under the HOCl modification. It was shown hemi-MPO to a lesser extent than dimeric MPO bound to platelets and enhanced their agonist-induced aggregation and platelet-neutrophil aggregate formation. MPO modified by HOCl and MPO in complex with CP did not bind to platelets and have no effect on platelet activity. Thus, the modification of MPO by HOCl, its presence in monomeric form as well as in complex with CP reduces MPO effect on platelet function and consequently decreases the risk of thrombosis in inflammatory foci.
Collapse
Affiliation(s)
- I V Gorudko
- Department of Biophysics, Faculty of Physics, Belarusian State University, 4 Nezavisimosti Avenue, Minsk, 220030, Belarus.
| | - D V Grigorieva
- Department of Biophysics, Faculty of Physics, Belarusian State University, 4 Nezavisimosti Avenue, Minsk, 220030, Belarus
| | - E V Shamova
- Institute of Biophysics and Сell Engineering of National Academy of Sciences of Belarus, 27 Academicheskaya Str., Minsk, 220072, Belarus
| | - N P Gorbunov
- FSBRI "Institute of Experimental Medicine", 12 Acad. Pavlov Str., St. Petersburg, 197376, Russia; Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 1a Malaya Pirogovskaya Str., Moscow, 119435, Russia
| | - A U Kokhan
- Institute of Biophysics and Сell Engineering of National Academy of Sciences of Belarus, 27 Academicheskaya Str., Minsk, 220072, Belarus
| | - V A Kostevich
- FSBRI "Institute of Experimental Medicine", 12 Acad. Pavlov Str., St. Petersburg, 197376, Russia; Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 1a Malaya Pirogovskaya Str., Moscow, 119435, Russia
| | - V B Vasilyev
- FSBRI "Institute of Experimental Medicine", 12 Acad. Pavlov Str., St. Petersburg, 197376, Russia
| | - O M Panasenko
- Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 1a Malaya Pirogovskaya Str., Moscow, 119435, Russia; Pirogov Russian National Research Medical University, 1 Ostrovityanova Str., Moscow, 117997, Russia
| | - N V Khinevich
- Belarusian State University of Informatics and Radioelectronics, 6 P. Brovka Str., Minsk, 220013, Belarus; Institute of Materials Science, Kaunas University of Technology, K. Donelaičio g. 73, Kaunas, 44249, Lithuania
| | - H V Bandarenka
- Belarusian State University of Informatics and Radioelectronics, 6 P. Brovka Str., Minsk, 220013, Belarus; Polytechnic School, Arizona State University, Arizona State University Polytechnicm, 7001 East Williams Field Road, Mesa, AZ, 85212, USA
| | - A A Burko
- Belarusian State University of Informatics and Radioelectronics, 6 P. Brovka Str., Minsk, 220013, Belarus; Polytechnic School, Arizona State University, Arizona State University Polytechnicm, 7001 East Williams Field Road, Mesa, AZ, 85212, USA
| | - A V Sokolov
- FSBRI "Institute of Experimental Medicine", 12 Acad. Pavlov Str., St. Petersburg, 197376, Russia; Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 1a Malaya Pirogovskaya Str., Moscow, 119435, Russia
| |
Collapse
|
6
|
Varatnitskaya M, Fasel J, Müller A, Lupilov N, Shi Y, Fuchs K, Krewing M, Jung C, Jacob T, Sitek B, Bandow JE, Carroll KS, Hoffmann E, Leichert LI. An increase in surface hydrophobicity mediates chaperone activity in N-chlorinated RidA. Redox Biol 2022; 53:102332. [PMID: 35598378 PMCID: PMC9126958 DOI: 10.1016/j.redox.2022.102332] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2022] [Revised: 04/29/2022] [Accepted: 05/04/2022] [Indexed: 11/29/2022] Open
Abstract
Under physiological conditions, Escherichia coli RidA is an enamine/imine deaminase, which promotes the release of ammonia from reactive enamine/imine intermediates. However, when modified by hypochlorous acid (HOCl), it turns into a potent chaperone-like holdase that can effectively protect E. coli's proteome during oxidative stress. However, it is unknown, which residues need to be chlorinated for activation. Here, we employ a combination of LC-MS/MS analysis, a chemo-proteomic approach, and a mutagenesis study to identify residues responsible for RidA's chaperone-like function. Through LC-MS/MS of digested RidAHOCl, we obtained direct evidence of the chlorination of one arginine residue. To overcome the instability of the N-chloramine modification, we established a chemoproteomic approach using 5-(dimethylamino) naphthalene-1-sulfinic acid (DANSO2H) as a probe to label N-chlorinated lysines. Using this probe, we were able to detect the N-chlorination of six additional lysine residues. Moreover, using a mutagenesis study to genetically probe the role of single arginine and lysine residues, we found that the removal of arginines R105 and/or R128 led to a substantial reduction of RidAHOCl's chaperone activity. These results, together with structural analysis, confirm that the chaperone activity of RidA is concomitant with the loss of positive charges on the protein surface, leading to an increased overall protein hydrophobicity. Molecular modelling of RidAHOCl and the rational design of a RidA variant that shows chaperone activity even in the absence of HOCl further supports our hypothesis. Our data provide a molecular mechanism for HOCl-mediated chaperone activity found in RidA and a growing number of other HOCl-activated chaperones.
Collapse
|
7
|
Snell JA, Jandova J, Wondrak GT. Hypochlorous Acid: From Innate Immune Factor and Environmental Toxicant to Chemopreventive Agent Targeting Solar UV-Induced Skin Cancer. Front Oncol 2022; 12:887220. [PMID: 35574306 PMCID: PMC9106365 DOI: 10.3389/fonc.2022.887220] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2022] [Accepted: 03/31/2022] [Indexed: 12/15/2022] Open
Abstract
A multitude of extrinsic environmental factors (referred to in their entirety as the 'skin exposome') impact structure and function of skin and its corresponding cellular components. The complex (i.e. additive, antagonistic, or synergistic) interactions between multiple extrinsic (exposome) and intrinsic (biological) factors are important determinants of skin health outcomes. Here, we review the role of hypochlorous acid (HOCl) as an emerging component of the skin exposome serving molecular functions as an innate immune factor, environmental toxicant, and topical chemopreventive agent targeting solar UV-induced skin cancer. HOCl [and its corresponding anion (OCl-; hypochlorite)], a weak halogen-based acid and powerful oxidant, serves two seemingly unrelated molecular roles: (i) as an innate immune factor [acting as a myeloperoxidase (MPO)-derived microbicidal factor] and (ii) as a chemical disinfectant used in freshwater processing on a global scale, both in the context of drinking water safety and recreational freshwater use. Physicochemical properties (including redox potential and photon absorptivity) determine chemical reactivity of HOCl towards select biochemical targets [i.e. proteins (e.g. IKK, GRP78, HSA, Keap1/NRF2), lipids, and nucleic acids], essential to its role in innate immunity, antimicrobial disinfection, and therapeutic anti-inflammatory use. Recent studies have explored the interaction between solar UV and HOCl-related environmental co-exposures identifying a heretofore unrecognized photo-chemopreventive activity of topical HOCl and chlorination stress that blocks tumorigenic inflammatory progression in UV-induced high-risk SKH-1 mouse skin, a finding with potential implications for the prevention of human nonmelanoma skin photocarcinogenesis.
Collapse
Affiliation(s)
| | | | - Georg T. Wondrak
- Department of Pharmacology and Toxicology, R.K. Coit College of Pharmacy & UA Cancer Center, University of Arizona, Tucson, AZ, United States
| |
Collapse
|
8
|
Hawkins CL, Davies MJ. Role of myeloperoxidase and oxidant formation in the extracellular environment in inflammation-induced tissue damage. Free Radic Biol Med 2021; 172:633-651. [PMID: 34246778 DOI: 10.1016/j.freeradbiomed.2021.07.007] [Citation(s) in RCA: 56] [Impact Index Per Article: 18.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/04/2021] [Revised: 07/04/2021] [Accepted: 07/05/2021] [Indexed: 12/30/2022]
Abstract
The heme peroxidase family generates a battery of oxidants both for synthetic purposes, and in the innate immune defence against pathogens. Myeloperoxidase (MPO) is the most promiscuous family member, generating powerful oxidizing species including hypochlorous acid (HOCl). Whilst HOCl formation is important in pathogen removal, this species is also implicated in host tissue damage and multiple inflammatory diseases. Significant oxidant formation and damage occurs extracellularly as a result of MPO release via phagolysosomal leakage, cell lysis, extracellular trap formation, and inappropriate trafficking. MPO binds strongly to extracellular biomolecules including polyanionic glycosaminoglycans, proteoglycans, proteins, and DNA. This localizes MPO and subsequent damage, at least partly, to specific sites and species, including extracellular matrix (ECM) components and plasma proteins/lipoproteins. Biopolymer-bound MPO retains, or has enhanced, catalytic activity, though evidence is also available for non-catalytic effects. These interactions, particularly at cell surfaces and with the ECM/glycocalyx induce cellular dysfunction and altered gene expression. MPO binds with higher affinity to some damaged ECM components, rationalizing its accumulation at sites of inflammation. MPO-damaged biomolecules and fragments act as chemo-attractants and cell activators, and can modulate gene and protein expression in naïve cells, consistent with an increasing cycle of MPO adhesion, activity, damage, and altered cell function at sites of leukocyte infiltration and activation, with subsequent tissue damage and dysfunction. MPO levels are used clinically both diagnostically and prognostically, and there is increasing interest in strategies to prevent MPO-mediated damage; therapeutic aspects are not discussed as these have been reviewed elsewhere.
Collapse
Affiliation(s)
- Clare L Hawkins
- Department of Biomedical Sciences, University of Copenhagen, Panum Institute, Blegdamsvej 3B, Copenhagen N, DK-2200, Denmark
| | - Michael J Davies
- Department of Biomedical Sciences, University of Copenhagen, Panum Institute, Blegdamsvej 3B, Copenhagen N, DK-2200, Denmark.
| |
Collapse
|
9
|
Peloi KE, Ratti BA, Nakamura CV, Neal CJ, Sakthivel TS, Singh S, Seal S, de Oliveira Silva Lautenschlager S. Engineered nanoceria modulate neutrophil oxidative response to low doses of UV-B radiation through the inhibition of reactive oxygen species production. J Biomed Mater Res A 2021; 109:2570-2579. [PMID: 34173708 DOI: 10.1002/jbm.a.37251] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2020] [Revised: 06/16/2021] [Accepted: 06/17/2021] [Indexed: 11/06/2022]
Abstract
To avoid aging and ultraviolet mediated skin disease the cell repair machinery must work properly. Neutrophils, also known as polymorphonuclear leukocytes, are the first and most abundant cell types which infiltrate sites of irradiation and play an important role in restoring the microenvironment homeostasis. However, the infiltration of neutrophils in ultraviolet-B (UV-B) irradiated skin might also contribute to the pathophysiology of skin disease. The polymorphonuclear leukocytes activation induced by UV-B exposure may lead to prolonged, sustained NADPH oxidase activation followed by an increase in reactive oxygen species (ROS) production. Our previous work showed that cerium oxide nanoparticles can protect L929 fibroblasts from ultraviolet-B induced damage. Herein, we further our investigation of engineered cerium oxide nanoparticles (CNP) in conferring radiation protection specifically in modulation of neutrophils' oxidative response under low dose of UV-B radiation. Our data showed that even low doses of UV-B radiation activate neutrophils' oxidative response and that the antioxidant, ROS-sensitive redox activities of engineered CNPs are able to inhibit the effects of NADPH oxidase activation while conferring catalase and superoxide dismutase mimetic activity. Further, our investigations revealed similar levels of total ROS scavenging for both CNP formulations, despite substantial differences in cerium redox states and specific enzyme-mimetic reaction activity. We therefore determine that CNP activity in mitigating the effects of neutrophils' oxidative response, through the decrease of ROS and of cell damage such as chromatin condensation, suggests potential utility as a radio-protectant/therapeutic against UV-B damage.
Collapse
Affiliation(s)
- Karen Elaine Peloi
- Post-Graduate Program in Pharmaceutical Sciences, State University of Maringá, Maringá, Paraná, Brazil
| | - Bianca Altrão Ratti
- Post-Graduate Program in Pharmaceutical Sciences, State University of Maringá, Maringá, Paraná, Brazil
| | - Celso Vataru Nakamura
- Post-Graduate Program in Pharmaceutical Sciences, State University of Maringá, Maringá, Paraná, Brazil
| | - Craig J Neal
- Nanoscience Technology Center, Advanced Materials Processing and Analysis Center, Department of Materials Science and Engineering, College of Medicine, University of Central Florida, Orlando, Florida, USA
| | - Tamil Selvan Sakthivel
- Nanoscience Technology Center, Advanced Materials Processing and Analysis Center, Department of Materials Science and Engineering, College of Medicine, University of Central Florida, Orlando, Florida, USA
| | - Sushant Singh
- Nanoscience Technology Center, Advanced Materials Processing and Analysis Center, Department of Materials Science and Engineering, College of Medicine, University of Central Florida, Orlando, Florida, USA.,Amity Institute of Biotechnology, Amity University Chhattisgarh, Raipur, Chhattisgarh, India
| | - Sudpita Seal
- Nanoscience Technology Center, Advanced Materials Processing and Analysis Center, Department of Materials Science and Engineering, College of Medicine, University of Central Florida, Orlando, Florida, USA.,College of Medicine, University of Central Florida, Orlando, Florida, USA
| | | |
Collapse
|
10
|
Ulfig A, Bader V, Varatnitskaya M, Lupilov N, Winklhofer KF, Leichert LI. Hypochlorous acid-modified human serum albumin suppresses MHC class II - dependent antigen presentation in pro-inflammatory macrophages. Redox Biol 2021; 43:101981. [PMID: 33940547 PMCID: PMC8105673 DOI: 10.1016/j.redox.2021.101981] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2021] [Revised: 04/13/2021] [Accepted: 04/15/2021] [Indexed: 12/14/2022] Open
Abstract
Macrophages are innate immune cells that internalize and present exogenous antigens to T cells via MHC class II proteins. They operate at sites of infection in a highly inflammatory environment, generated in part by reactive oxygen species, in particular the strong oxidant hypochlorous acid (HOCl) produced in the neutrophil respiratory burst. HOCl effectively kills a broad range of pathogens but can also contribute to host tissue damage at sites of inflammation. To prevent tissue injury, HOCl is scavenged by human serum albumin (HSA) and other plasma proteins in interstitial fluids, leading to the formation of variously modified advanced oxidation products (AOPPs) with pro-inflammatory properties. Previously, we showed that HOCl-mediated N-chlorination converts HSA and other plasma proteins into efficient activators of the phagocyte respiratory burst, but the role of these AOPPs in antigen presentation by macrophages remained unclear. Here, we show that physiologically relevant amounts of N-chlorinated HSA can strongly impair the capacity of THP-1-derived macrophages to present antigens to antigen-specific T cells via MHC class II proteins at multiple stages. Initially, N-chlorinated HSA inhibits antigen internalization by converting antigens into scavenger receptor (SR) ligands and competing with the modified antigens for binding to SR CD36. Later steps of antigen presentation, such as intracellular antigen processing and MHC class II expression are negatively affected, as well. We propose that impaired processing of pathogens or exogenous antigens by immune cells at an initial stage of infection prevents antigen presentation in an environment potentially hostile to cells of the adaptive immune response, possibly shifting it towards locations removed from the actual insult, like the lymph nodes. On the flip side, excessive retardation or complete inhibition of antigen presentation by N-chlorinated plasma proteins could contribute to chronic infection and inflammation.
Collapse
Affiliation(s)
- Agnes Ulfig
- Ruhr University Bochum, Institute of Biochemistry and Pathobiochemistry - Microbial Biochemistry, Universitätsstrasse 150, 44780, Bochum, Germany
| | - Verian Bader
- Ruhr University Bochum, Institute of Biochemistry and Pathobiochemistry - Molecular Cell Biology, Universitätsstrasse 150, 44780, Bochum, Germany
| | - Marharyta Varatnitskaya
- Ruhr University Bochum, Institute of Biochemistry and Pathobiochemistry - Microbial Biochemistry, Universitätsstrasse 150, 44780, Bochum, Germany
| | - Natalie Lupilov
- Ruhr University Bochum, Institute of Biochemistry and Pathobiochemistry - Microbial Biochemistry, Universitätsstrasse 150, 44780, Bochum, Germany
| | - Konstanze F Winklhofer
- Ruhr University Bochum, Institute of Biochemistry and Pathobiochemistry - Molecular Cell Biology, Universitätsstrasse 150, 44780, Bochum, Germany
| | - Lars I Leichert
- Ruhr University Bochum, Institute of Biochemistry and Pathobiochemistry - Microbial Biochemistry, Universitätsstrasse 150, 44780, Bochum, Germany.
| |
Collapse
|
11
|
Ulfig A, Leichert LI. The effects of neutrophil-generated hypochlorous acid and other hypohalous acids on host and pathogens. Cell Mol Life Sci 2021; 78:385-414. [PMID: 32661559 PMCID: PMC7873122 DOI: 10.1007/s00018-020-03591-y] [Citation(s) in RCA: 109] [Impact Index Per Article: 36.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2020] [Revised: 06/21/2020] [Accepted: 07/01/2020] [Indexed: 12/15/2022]
Abstract
Neutrophils are predominant immune cells that protect the human body against infections by deploying sophisticated antimicrobial strategies including phagocytosis of bacteria and neutrophil extracellular trap (NET) formation. Here, we provide an overview of the mechanisms by which neutrophils kill exogenous pathogens before we focus on one particular weapon in their arsenal: the generation of the oxidizing hypohalous acids HOCl, HOBr and HOSCN during the so-called oxidative burst by the enzyme myeloperoxidase. We look at the effects of these hypohalous acids on biological systems in general and proteins in particular and turn our attention to bacterial strategies to survive HOCl stress. HOCl is a strong inducer of protein aggregation, which bacteria can counteract by chaperone-like holdases that bind unfolding proteins without the need for energy in the form of ATP. These chaperones are activated by HOCl through thiol oxidation (Hsp33) or N-chlorination of basic amino acid side-chains (RidA and CnoX) and contribute to bacterial survival during HOCl stress. However, neutrophil-generated hypohalous acids also affect the host system. Recent studies have shown that plasma proteins act not only as sinks for HOCl, but get actively transformed into modulators of the cellular immune response through N-chlorination. N-chlorinated serum albumin can prevent aggregation of proteins, stimulate immune cells, and act as a pro-survival factor for immune cells in the presence of cytotoxic antigens. Finally, we take a look at the emerging role of HOCl as a potential signaling molecule, particularly its role in neutrophil extracellular trap formation.
Collapse
Affiliation(s)
- Agnes Ulfig
- Ruhr University Bochum, Institute for Biochemistry and Pathobiochemistry-Microbial Biochemistry, Universitätsstrasse 150, 44780, Bochum, Germany
| | - Lars I Leichert
- Ruhr University Bochum, Institute for Biochemistry and Pathobiochemistry-Microbial Biochemistry, Universitätsstrasse 150, 44780, Bochum, Germany.
| |
Collapse
|
12
|
Mañucat-Tan N, Zeineddine Abdallah R, Kaur H, Saviane D, Wilson MR, Wyatt AR. Hypochlorite-induced aggregation of fibrinogen underlies a novel antioxidant role in blood plasma. Redox Biol 2020; 40:101847. [PMID: 33440293 PMCID: PMC7808953 DOI: 10.1016/j.redox.2020.101847] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2020] [Revised: 12/20/2020] [Accepted: 12/22/2020] [Indexed: 01/02/2023] Open
Abstract
Fibrinogen, a major constituent of blood plasma, is highly susceptible to reaction with biological oxidants. It has been proposed that fibrinogen plays a role in antioxidant defence, but oxidation of fibrinogen is also known to disrupt normal blood clotting and is implicated in the pathology of atherosclerosis. In the present study, we show that the biological oxidant hypochlorite promotes the formation of soluble high molecular weight fibrinogen assemblies ≥40 × 106 Da, that do not accumulate when fibrinogen is induced to aggregate by other stresses such as heating or hydroxyl-mediated damage in vitro. Hypochlorite-modified fibrinogen is stable at 37 °C as assessed by precipitation assays, and has reduced susceptibility to iron-induced (hydroxyl-mediated) precipitation compared to native fibrinogen. In contrast to hypochlorite-modified albumin, which is known to be immunostimulatory, hypochlorite-modified fibrinogen does not induce RAW 264.7 (macrophage-like) cells or EOC 13.31 (microglia-like) cells to produce reactive oxygen species or induce cell death. Furthermore, depletion of fibrinogen from human blood plasma increases the immunostimulatory property of blood plasma after it is supplemented with hypochlorite in situ. We propose that reaction of hypochlorite with fibrinogen in blood plasma potentially reduces the accumulation of other hypochlorite-modified species such as immunostimulatory hypochlorite-modified albumin. The latter represent a novel role for fibrinogen in blood plasma antioxidant defence.
Collapse
Affiliation(s)
- Noralyn Mañucat-Tan
- Flinders Health and Medical Research Institute and College of Medicine and Public Health, Flinders University, Bedford Park, Australia
| | - Rafaa Zeineddine Abdallah
- Molecular Horizons and the School of Chemistry and Molecular Bioscience, University of Wollongong, Northfields Avenue, Wollongong, Australia; Illawarra Health and Medical Research Institute, Northfields Avenue, Wollongong, Australia
| | - Harsimran Kaur
- Flinders Health and Medical Research Institute and College of Medicine and Public Health, Flinders University, Bedford Park, Australia
| | - Daniel Saviane
- Flinders Health and Medical Research Institute and College of Medicine and Public Health, Flinders University, Bedford Park, Australia
| | - Mark R Wilson
- Molecular Horizons and the School of Chemistry and Molecular Bioscience, University of Wollongong, Northfields Avenue, Wollongong, Australia; Illawarra Health and Medical Research Institute, Northfields Avenue, Wollongong, Australia
| | - Amy R Wyatt
- Flinders Health and Medical Research Institute and College of Medicine and Public Health, Flinders University, Bedford Park, Australia.
| |
Collapse
|
13
|
Varatnitskaya M, Degrossoli A, Leichert LI. Redox regulation in host-pathogen interactions: thiol switches and beyond. Biol Chem 2020; 402:299-316. [PMID: 33021957 DOI: 10.1515/hsz-2020-0264] [Citation(s) in RCA: 16] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2020] [Accepted: 09/29/2020] [Indexed: 12/23/2022]
Abstract
Our organism is exposed to pathogens on a daily basis. Owing to this age-old interaction, both pathogen and host evolved strategies to cope with these encounters. Here, we focus on the consequences of the direct encounter of cells of the innate immune system with bacteria. First, we will discuss the bacterial strategies to counteract powerful reactive species. Our emphasis lies on the effects of hypochlorous acid (HOCl), arguably the most powerful oxidant produced inside the phagolysosome of professional phagocytes. We will highlight individual examples of proteins in gram-negative bacteria activated by HOCl via thiol-disulfide switches, methionine sulfoxidation, and N-chlorination of basic amino acid side chains. Second, we will discuss the effects of HOCl on proteins of the host. Recent studies have shown that both host and bacteria address failing protein homeostasis by activation of chaperone-like holdases through N-chlorination. After discussing the role of individual proteins in the HOCl-defense, we will turn our attention to the examination of effects on host and pathogen on a systemic level. Recent studies using genetically encoded redox probes and redox proteomics highlight differences in redox homeostasis in host and pathogen and give first hints at potential cellular HOCl signaling beyond thiol-disulfide switch mechanisms.
Collapse
Affiliation(s)
- Marharyta Varatnitskaya
- Institute for Biochemistry and Pathobiochemistry - Microbial Biochemistry, Ruhr University Bochum, Bochum, Germany
| | - Adriana Degrossoli
- Faculty of Health Science - Health Science Department, Federal University of Lavras, Lavras, Brazil
| | - Lars I Leichert
- Institute for Biochemistry and Pathobiochemistry - Microbial Biochemistry, Ruhr University Bochum, Bochum, Germany
| |
Collapse
|
14
|
Rahman MM, Ferdous KU, Roy S, Nitul IA, Mamun F, Hossain MH, Subhan N, Alam MA, Haque MA. Polyphenolic compounds of amla prevent oxidative stress and fibrosis in the kidney and heart of 2K1C rats. Food Sci Nutr 2020; 8:3578-3589. [PMID: 32724620 PMCID: PMC7382108 DOI: 10.1002/fsn3.1640] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2020] [Revised: 03/20/2020] [Accepted: 04/24/2020] [Indexed: 02/06/2023] Open
Abstract
Amla (Emblica officinalis Gaertn.) is a natural source of antioxidants and possesses valuable medicinal properties. However, the protective effect of amla in the kidney of two-kidneys-one-clip (2K1C) rats has not been explained sufficiently. This study was performed to evaluate the renoprotective effect of amla fruit powder (2.5% W/W) supplementation in kidneys of 2K1C rats. 2K1C rats increased the remnant kidney wet weight and also increased plasma creatinine and uric acid concentration compared to the control. Amla supplementation ameliorates elevated creatinine and uric acid concentration in plasma of 2K1C rats. Various oxidative stress indicators such as malondialdehyde, nitric oxide (NO), and advanced protein oxidation product (APOP) were also increased in plasma, heart, and kidney tissues in 2K1C rats that were also significantly brought down to normal level by amla supplementation. Moreover, the inflammatory cells entry and fibrosis in the 2K1C rat's tissues were prevented by amla supplementation. These research results suggest that amla may restore plasma antioxidant capacities and prevents oxidative stress, inflammation, and fibrosis in 2K1C rats. Taken these results as a base, clinical supplementation of dried amla powder in diet or juice to the CKD patients would be beneficial.
Collapse
Affiliation(s)
- Md. Mizanur Rahman
- Department of Pharmaceutical SciencesNorth South UniversityDhakaBangladesh
| | | | - Shraboni Roy
- Department of Pharmaceutical SciencesNorth South UniversityDhakaBangladesh
| | - Iffat Ara Nitul
- Department of Pharmaceutical SciencesNorth South UniversityDhakaBangladesh
| | - Fariha Mamun
- Department of Pharmaceutical SciencesNorth South UniversityDhakaBangladesh
| | - Md. Hemayet Hossain
- BCSIR LaboratoriesBangladesh Council of Scientific and Industrial ResearchDhakaBangladesh
| | - Nusrat Subhan
- Department of Pharmaceutical SciencesNorth South UniversityDhakaBangladesh
| | - Md Ashraful Alam
- Department of Pharmaceutical SciencesNorth South UniversityDhakaBangladesh
| | - Md. Areeful Haque
- Department of PharmacyInternational Islamic University ChittagongChittagongBangladesh
- Drug and Herbal Research Centre, Faculty of PharmacyUniversiti Kebangsaan MalaysiaKuala LumpurMalaysia
| |
Collapse
|
15
|
Abstract
Neutrophils kill invading microbes and therefore represent the first line of defense of the innate immune response. Activated neutrophils assemble NADPH oxidase to convert substantial amounts of molecular oxygen into superoxide, which, after dismutation into peroxide, serves as the substrate for the generation of the potent antimicrobial hypochlorous acid (HOCl) in the phagosomal space. In this minireview, we explore the most recent insights into physiological consequences of HOCl stress. Not surprisingly, Gram-negative bacteria have evolved diverse posttranslational defense mechanisms to protect their proteins, the main targets of HOCl, from HOCl-mediated damage. We discuss the idea that oxidation of conserved cysteine residues and partial unfolding of its structure convert the heat shock protein Hsp33 into a highly active chaperone holdase that binds unfolded proteins and prevents their aggregation. We examine two novel members of the Escherichia coli chaperone holdase family, RidA and CnoX, whose thiol-independent activation mechanism differs from that of Hsp33 and requires N-chlorination of positively charged amino acids during HOCl exposure. Furthermore, we summarize the latest findings with respect to another bacterial defense strategy employed in response to HOCl stress, which involves the accumulation of the universally conserved biopolymer inorganic polyphosphate. We then discuss sophisticated adaptive strategies that bacteria have developed to enhance their survival during HOCl stress. Understanding bacterial defense and survival strategies against one of the most powerful neutrophilic oxidants may provide novel insights into treatment options that potentially compromise the ability of pathogens to resist HOCl stress and therefore may increase the efficacy of the innate immune response.
Collapse
|
16
|
Goemans CV, Collet JF. Stress-induced chaperones: a first line of defense against the powerful oxidant hypochlorous acid. F1000Res 2019; 8. [PMID: 31583082 PMCID: PMC6758839 DOI: 10.12688/f1000research.19517.1] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 09/18/2019] [Indexed: 01/12/2023] Open
Abstract
Hypochlorous acid (HOCl; bleach) is a powerful weapon used by our immune system to eliminate invading bacteria. Yet the way HOCl actually kills bacteria and how they defend themselves from its oxidative action have only started to be uncovered. As this molecule induces both protein oxidation and aggregation, bacteria need concerted efforts of chaperones and antioxidants to maintain proteostasis during stress. Recent advances in the field identified several stress-activated chaperones, like Hsp33, RidA, and CnoX, which display unique structural features and play a central role in protecting the bacterial proteome during HOCl stress.
Collapse
Affiliation(s)
- Camille V Goemans
- European Molecular Biology Laboratory, Meyerhofstrasse 1, 69117, Heidelberg, Germany
| | | |
Collapse
|